Pavmed’s Lucid Diagnostics enters clinical trial with U of Penn
Categories
Pavmed announced today that its majority-owned subsidiary Lucid Diagnostics entered into a clinical trial research agreement with the University of Pennsylvania to observe its EsoCheck esophageal cell collection device.